Mitochondrial translocation of human telomerase reverse transcriptase in cord blood mononuclear cells of newborns with gestational diabetes mellitus mothers

Diabetes Research and Clinical Practice

Volumn 103, Issue 2, 2014, Pages 310-318

  Li, Ping ^a,b,c   Tong, Yu ^b,c   Yang, Huiming ^a   Zhou, Shu ^a   Xiong, Fei ^a   Huo, Tingzhu ^a   Mao, Meng ^b,c,d  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Key Lab of Obst and Gyn and Pediatric Dis and Birth Defects of Min of Educ   (China)

^d CHENGDU WOMEN S AND CHILDREN S CENTRAL HOSPITAL   (China)

Author keywords

Fetal programming; Gestational diabetes; Mitochondrial hTERT; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; MITOCHONDRIAL DNA; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE; TERT PROTEIN, HUMAN;

ADULT; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA CONTENT; ENZYME BLOOD LEVEL; ENZYME LOCALIZATION; FEMALE; FETUS MONITORING; HUMAN; MALE; MATERNAL BLOOD; MITOCHONDRIAL DYNAMICS; MONONUCLEAR CELL; NEWBORN; OXIDATIVE STRESS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD; WESTERN BLOTTING; BLOOD; CHILD; FETUS BLOOD; FETUS DEVELOPMENT; GENETICS; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ADULT; CHILD OF IMPAIRED PARENTS; DIABETES, GESTATIONAL; DNA, MITOCHONDRIAL; FEMALE; FETAL BLOOD; FETAL DEVELOPMENT; HUMANS; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREGNANCY; TELOMERASE;

EID: 84895783032     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.12.024     Document Type: Article

References (46)

1. Metzger B.E., Coustan D.R. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998, 21:B161.
2. Shaat N., Groop L. Genetics of gestational diabetes mellitus. Curr Med Chem 2007, 14:569-583.
3. Lee H., Jang H.C., Park H.K., Cho N.H. Early manifestation of cardiovascular disease risk factors in offspring of mothers with previous history of gestational diabetes mellitus. Diabetes Res Clin Pract 2007, 78:238-245.
4. Reece E.A. The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2010, 23:199-203.
5. Persson M., Fadl H., Hanson U., Pasupathy D. Disproportionate body composition and neonatal outcome in offspring of mothers with and without gestational diabetes mellitus. Diabetes Care 2013, 36:3543-3548.
6. Vrachnis N., Antonakopoulos N., Iliodromiti Z., Dafopoulos K., Siristatidis C., Pappa K.I., et al. Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring. Exp Diabetes Res 2012, 2012:538474.
7. Wang Q., Huang R., Yu B., Cao F., Wang H., Zhang M., et al. Higher fetal insulin resistance in Chinese pregnant women with gestational diabetes mellitus and correlation with maternal insulin resistance. PLoS One 2013, 8:e59845.
8. Mcmillen I.C., Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005, 85:571-633.
9. Bateson P., Barker D., Clutton-Brock T., Deb D., D'Udine B., Foley R.A., et al. Developmental plasticity and human health. Nature 2004, 430:419-421.
10. Dennery P.A. Oxidative stress in development: nature or nurture. Free Radic Biol Med 2010, 49:1147-1151.
11. Palm M., Axelsson O., Wernroth L., Basu S. F(2)-isoprostanes, tocopherols and normal pregnancy. Free Radic Res 2009, 43:546-552.
12. Simmons R.A. Developmental origins of diabetes: the role of oxidative stress. Free Radic Biol Med 2006, 40:917-922.
13. Luo Z., Fraser W., Julien P., Deal C.L., Audibert F., Smith G.N., et al. Tracing the origins of fetal origins of adult diseases: programming by oxidative stress. Med Hypotheses 2006, 66:38-44.
14. Lappas M., Hiden U., Desoye G., Froehlich J., Hauguel-de Mouzon S., Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal 2011, 15:3061-3100.
15. Thompson L.P., Al-Hasan Y. Impact of oxidative stress in fetal programming. J Pregnancy 2012, 2012:582748.
16. Lappas M., Permezel M., Rice G.E. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 2004, 89:5627-5633.
17. Toescu V., Nuttall S., Martin U., Nightingale P., Kendall M.J., Brydon P., et al. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci 2004, 106:93-98.
18. Rajdl D., Racek J., Steinerova A., Novotny Z., Stozicky F., Trefil L., et al. Markers of oxidative stress in diabetic mothers and their infants during delivery. Physiol Res 2005, 54:429.
19. Biri A., Onan A., Devrim E., Babacan F., Kavutcu M., Durak I. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 2006, 27:327-332.
20. Chiavaroli V., Giannini C., D'Adamo E., de Giorgis T., Chiarelli F., Mohn A. Insulin resistance and oxidative stress in children born small and large for gestational age. Pediatrics 2009, 124:695-702.
21. Chen Y.C., Sheen J.M., Tiao M.M., Tain Y.L., Huang L.T. Roles of melatonin in fetal programming in compromised pregnancies. Int J Mol Sci 2013, 14:5380-5401.
22. Strakovsky R.S., Pan Y.X. In utero oxidative stress epigenetically programs antioxidant defense capacity and adulthood diseases. Antioxid Redox Signal 2012, 17:237-253.
23. Murphy M. How mitochondria produce reactive oxygen species. Biochem J 2009, 417:1-13.
24. Pejznochova M., Tesarova M., Honzik T., Hansikova H., Magner M., Zeman J. The developmental changes in mitochondrial DNA content per cell in human cord blood leukocytes during gestation. Physiol Res 2008, 57:947-955.
25. Pejznochova M., Tesarova M., Hansikova H., Magner M., Honzik T., Vinsova K., et al. Mitochondrial DNA content and expression of genes involved in mtDNA transcription, regulation and maintenance during human fetal development. Mitochondrion 2010, 10:321-329.
26. Malik A.N., Czajka A. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction. Mitochondrion 2013, 13:481-492.
27. Santos J.H., Meyer J.N., Skorvaga M., Annab L.A., Van Houten B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 2004, 3:399-411.
28. Santos J.H., Meyer J.N., Van Houten B. Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Human Mol Genet 2006, 15:1757-1768.
29. Ahmed S., Passos J.F., Birket M.J., Beckmann T., Brings S., Peters H., et al. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 2008, 121:1046-1053.
30. Haendeler J., Drose S., Buchner N., Jakob S., Altschmied J., Goy C., et al. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 2009, 29:929-935.
31. Jakob S., Haendeler J. Molecular mechanisms involved in endothelial cell aging: role of telomerase reverse transcriptase. Zeitschrift für Gerontologie und Geriatrie 2007, 40:334-338.
32. 2 is Src kinase dependent. Exp Gerontol 2010, 45:558-562.
33. Indran I.R., Hande M.P., Pervaiz S. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res 2011, 71:266-276.
34. Ling X., Wen L., Zhou Y. Role of mitochondrial translocation of telomerase in hepatocellular carcinoma cells with multidrug resistance. Int J Med Sci 2012, 9:545-554.
35. Sarikabadayi Y.U., Aydemir O., Aydemir C., Uras N., Oguz S.S., Erdeve O., et al. Umbilical cord oxidative stress in infants of diabetic mothers and its relation to maternal hyperglycemia. J Pediatr Endocrinol Metab 2011, 24:671-674.
36. Haendeler J., Hoffmann J., Brandes R.P., Zeihe A.M., Dimmeler S. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 2003, 23:4598-4610.
37. Barker D.J. The fetal and infant origins of adult disease. BMJ: Br Med J 1990, 301:1111.
38. Rinaudo P., Wang E. Fetal programming and metabolic syndrome. Annu Rev Physiol 2012, 74:107-130.
39. Haendeler J., Hoffmann J., Diehl J.F., Vasa M., Spyridopoulos I., Zeiher A.M., et al. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 2004, 94:768-775.
40. Sharma N.K., Reyes A., Green P., Caron M.J., Bonini M.G., Gordon D.M., et al. Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria. Nucleic Acids Res 2012, 40:712-725.
41. Kim H., Lee S-H., Cho S., Kim Y.L., Han J.E., Cha K.Y. Decreased mitochondrial DNA (mtDNA) copy number determined by real-time PCR in patients with gestational diabetes mellitus (GDM). Fertil Steril 2004, 82:S296-S297.
42. Nakatsukasa Y., Tsukahara H., Tabuchi K., Tabuchi M., Magami T., Yamada M., et al. Thioredoxin-1 and oxidative stress status in pregnant women at early third trimester of pregnancy: relation to maternal and neonatal characteristics. J Clin Biochem Nutr 2013, 52:27-31.
43. Weinberger B., Nisar S., Anwar M., Ostfeld B., Hegyi T. Lipid peroxidation in cord blood and neonatal outcome. Pediatr Int 2006, 48:479-483.
44. Gveric-Ahmetasevic S., Sunjic S.B., Skala H., Andrisic L., Stroser M., Zarkovic K., et al. Oxidative stress in small-for-gestational age (SGA) term newborns and their mothers. Free Radic Res 2009, 43:376-384.
45. Gupta P., Narang M., Banerjee B., Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatr 2004, 4:14.
46. Kowaltowski A.J., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1999, 26:463-471.